Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study

Massimiliano Creta, Nicola Longo, Davide Arcaniolo, Riccardo Giannella, Tommaso Cai, Annarita Cicalese, Cosimo De Nunzio, Giovanni Grimaldi, Virgilio Cicalese, Marco De Sio, Riccardo Autorino, Estevao Lima, Paolo Fedelini, Mariano Marmo, Marco Capece, Roberto La Rocca, Andrea Tubaro, Ciro Imbimbo, Vincenzo Mirone, Ferdinando Fusco

Research output: Contribution to journalArticle

Abstract

Background: Evidence about the clinical benefits of Hyperbaric Oxygen Therapy (HBOT) in patients with Fournier's Gangrene (FG) is controversial and inconclusive. We aimed to compare the mortality related to FG between patients undergoing surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT. Methods: We performed a retrospective multi-institutional observational case-control study. All patients admitted with diagnosis of FG from June 2009 to June 2019 were included into the study. Patients received surgical debridement and/or standard antibiotic therapy alone or in combination with HBOT. Factors associated with FG related mortality were assessed with uni-and multivariate analyses. The main outcome measure was FG related mortality. Results: A total of 161 patients with diagnosis of FG were identified. Mean FG Severity Index was 8.6±4.5. All patients had broad-spectrum parenteral antibiotic therapy. An aggressive debridement was performed in 139 (86.3%) patients. A total of 72 patients (44.7%) underwent HBOT. Mortality due to FG was observed in 32 (36.0%) of patients who do not underwent HBOT and in 14 (19.4%) of patients who underwent HBOT (P=0.01). At the multivariate analysis, surgical debridement and HBOT were independent predictors of lower mortality while higher FG Severity Index was independent predictor of higher mortality. Conclusions: HBOT and surgical debridement are independent predictors of reduced FG related mortality.

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalMinerva Urologica e Nefrologica
Volume72
Issue number2
DOIs
Publication statusPublished - Apr 2020

Keywords

  • Fournier gangrene
  • Hyperbaric oxygenation
  • Mortality

ASJC Scopus subject areas

  • Nephrology
  • Urology

Fingerprint Dive into the research topics of 'Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study'. Together they form a unique fingerprint.

  • Cite this

    Creta, M., Longo, N., Arcaniolo, D., Giannella, R., Cai, T., Cicalese, A., De Nunzio, C., Grimaldi, G., Cicalese, V., De Sio, M., Autorino, R., Lima, E., Fedelini, P., Marmo, M., Capece, M., La Rocca, R., Tubaro, A., Imbimbo, C., Mirone, V., & Fusco, F. (2020). Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study. Minerva Urologica e Nefrologica, 72(2), 223-228. https://doi.org/10.23736/S0393-2249.20.03696-6